Ampco-Pittsburgh Subsidiary Accelerates Exit from U.K. Operations

Stock Information for AN2 Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AN2 Therapeutics Inc.

Ampco-Pittsburgh Corporation (NYSE: AP) Announces Third Quarter 2025 Results
Ampco-Pittsburgh Corporation to Present at the Three Part Advisors IDEAS Investor Conference on November 19, 2025 in Dallas, TX
Ampco-Pittsburgh Corporation (NYSE: AP) Announces CFO Transition
Ampco-Pittsburgh Schedules Third Quarter 2025 Earnings Conference Call
Ampco-Pittsburgh Corporation (NYSE: AP) Announces Second Quarter 2025 Results
Ampco-Pittsburgh Schedules Second Quarter 2025 Earnings Conference Call
Ampco-Pittsburgh Corporation Issues Reminder Regarding Warrant Expiration
Ampco-Pittsburgh Corporation Announces Closing of Amended and Restated Credit Facility

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.